Latest News

Compound reverses symptoms of Alzheimer's disease in mice

Research in an animal model supports the potential therapeutic value of an antisense compound to treat Alzheimer's disease. The molecule also reduced inflammation in the part of the brain responsible for learning and memory. The article is the second mouse study that supports the potential therapeutic value of an antisense compound in treating Alzheimer's disease in humans.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • From chick to bedside: Removing the Wnt barrier

  • Abnormal brain rhythms tied to problems with thinking in schizophrenia

  • Exposure to endocrine disruptors during pregnancy affects the brain two generations later, rat study shows

  • Autistic features linked to prenatal exposure to commonly found fire retardants, phthalates

  • Drug to control appetite could also fight anxiety

  • Human brains age less than previously thought

  • Neuroscientists perform important step towards cell therapy for diseases of the cerebral cortex

  • Why some brain cancers resist treatment

  • Mechanism behind most common form of inherited Alzheimer's disease revealed

  • Mental health soon after war-zone concussions predicts disability

  •